{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:15:26Z","timestamp":1778141726955,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001502","name":"Government of India Department of Atomic Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrc.2026.153759","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:57:47Z","timestamp":1776322667000},"page":"153759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["p53-R248W evades doxorubicin mediated cell death through collective alteration in TOP2A and CYP1A1 genes in cancer cells"],"prefix":"10.1016","volume":"819","author":[{"given":"Megha","family":"Mehrotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priti S.","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmita","family":"Sakpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourav","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritha","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bbrc.2026.153759_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026070","article-title":"p53 in the DNA-Damage-Repair process","volume":"6","author":"Williams","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153759_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/jcb.21091","article-title":"p53 modulation of the DNA damage response","volume":"100","author":"Helton","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153759_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0304-3835(01)00720-0","article-title":"Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells","volume":"175","author":"Qin","year":"2002","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153759_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1026476801463","article-title":"5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene","volume":"2","author":"Osaki","year":"1997","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2026.153759_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00289","article-title":"Mutant p53: one, no one, and one hundred thousand","volume":"5","author":"Walerych","year":"2015","journal-title":"Front. Oncol."},{"issue":"15","key":"10.1016\/j.bbrc.2026.153759_bib6","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/sj.onc.1210294","article-title":"Transcription regulation by mutant p53","volume":"26","author":"Weisz","year":"2007","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bbrc.2026.153759_bib7","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1101\/gad.190678.112","article-title":"Mutant p53: one name, many proteins","volume":"26","author":"Freed-Pastor","year":"2012","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153759_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When mutants gain new powers: news from the mutant p53 field","volume":"9","author":"Brosh","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153759_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/ijo.2014.2747","article-title":"TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma","volume":"46","author":"Brachova","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153759_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13046-024-03147-z","article-title":"Autophagy-mediated ID1 turnover dictates chemo-resistant fate in ovarian cancer stem cells","volume":"43","author":"Phadte","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153759_bib11","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/mc.70043","article-title":"Withaferin A exerts cytotoxicity in Single\/Multidrug-resistant gastric and ovarian cancer cells and tumor xenografts through the AKT-NF-\u03baB-STAT3-Survivin axis","volume":"64","author":"Shenoy","year":"2025","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153759_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13048-019-0492-6","article-title":"TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers","volume":"12","author":"Ghisoni","year":"2019","journal-title":"J. Ovarian Res."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153759_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ygeno.2012.11.009","article-title":"Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line","volume":"101","author":"AbuHammad","year":"2013","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153759_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00001813-200404000-00008","article-title":"Down-regulation of human topoisomerase IIalpha correlates with altered expression of transcriptional regulators NF-YA and Sp1","volume":"15","author":"Allen","year":"2004","journal-title":"Anti Cancer Drugs"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153759_bib15","first-page":"7","article-title":"Cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"14","key":"10.1016\/j.bbrc.2026.153759_bib16","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus Topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153759_bib17","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1038\/s41467-023-39867-7","article-title":"The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma","volume":"14","author":"Smith","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153759_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00280-004-0767-4","article-title":"Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line","volume":"53","author":"Chan","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153759_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nm0796-811","article-title":"Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients","volume":"2","author":"Aas","year":"1996","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153759_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2220\/biomedres.31.401","article-title":"Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells","volume":"31","author":"Yoshikawa","year":"2010","journal-title":"Biomed. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153759_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ygyno.2015.06.025","article-title":"TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin: TOP2A as marker of response to PLD in ovarian cancer","volume":"138","author":"Erriquez","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153759_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/mol.63.2.359","article-title":"Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs","volume":"63","author":"Joshi","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153759_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1128\/MCB.17.1.389","article-title":"Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor","volume":"17","author":"Wang","year":"1997","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153759_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00204-014-1409-1","article-title":"Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism","volume":"90","author":"Wohak","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbrc.2026.153759_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2018.02.006","article-title":"The impact of chemotherapeutic drugs on the CYP1A1-catalysed metabolism of the environmental carcinogen benzo[a]pyrene: effects in human colorectal HCT116 TP53(+\/+), TP53(+\/-) and TP53(-\/-) cells","volume":"398\u2013399","author":"Willis","year":"2018","journal-title":"Toxicology"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26005231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26005231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T07:58:10Z","timestamp":1778140690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26005231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":25,"alternative-id":["S0006291X26005231"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153759","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p53-R248W evades doxorubicin mediated cell death through collective alteration in TOP2A and CYP1A1 genes in cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153759"}}